Study shows 20% of migraine patients face care delays due to payer blocking strategies, leading to more ER visits.

A recent study discovered a correlation between insurance limitations on migraine medication and a rise in emergency visits and hospital admittances. The research identified that tactics like step therapy and prior authorization imposed by payers have been associated with this trend. The findings highlight the negative impact of these strategies, potentially leading to a surge in healthcare utilization. The study underscores the importance of addressing insurance constraints that hinder patients' access to necessary treatments for managing migraines.